A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/30/2002	EP0689449B1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
10/30/2002	CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002	CN1377414A Self-cleaving RNA sequences and their use for the control of protein synthesis
10/30/2002	CN1377409A MEG-1 protein
10/30/2002	CN1377408A The PRV-1 gene and use thereof
10/30/2002	CN1377371A Parathyroid hormone analogues for the treatment of osteoporosis
10/30/2002	CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002	CN1377283A Process to make a sustained release formulation
10/30/2002	CN1377280A Diagnosis and treatment of neuroectodermal tumors
10/30/2002	CN1377278A Prevention and treatment of amyloidogenic disease
10/30/2002	CN1377277A Use of leptin in inhibition of endothelial cell proliferation
10/30/2002	CN1377276A Protein polymerization inhibitors and methods of use
10/30/2002	CN1377275A Peptides that block viral infectivity and methods of use thereof
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377257A Hybrid matrices and hybrid matrix mixtures
10/30/2002	CN1377238A Composition comprising casein protein and whey protein
10/30/2002	CN1376798A Human acetylcholinesterase isomer protein (AR-ACHE) and its gene coding sequence
10/30/2002	CN1376791A Polypeptide-5-phosphate D-ribulose 3-isomerase-25.08 and polynucleotide for coding it
10/30/2002	CN1376790A Polypeptide-topoisomerase-18.48 and polynucleotide for coding it
10/30/2002	CN1376789A Polypeptide-human phosphotriesterase -22 and polynucleotide for coding it
10/30/2002	CN1376788A Polypeptide-human tyrosine phosphatase -20.68 and polynucletoide for coding it
10/30/2002	CN1376787A Polypeptide-tyrosine protein kinase -58.32 and polynucleotide for coding it
10/30/2002	CN1376786A Polypeptide-human Ser/Thr protein kinase -36.08 and polynucletoide for coding it
10/30/2002	CN1376785A Polypeptide-thiamine pyrophosphate kinase -26.73 and polynucleotide for coding it
10/30/2002	CN1376784A Polypeptide-acetylgucosamine transferase GNT1-30.36 and polynucletoide for coding it
10/30/2002	CN1376782A Polypeptide-human histidine deacetylase-14.96 and polynucelotide for coding it
10/30/2002	CN1376781A Polypeptide-pyruvate phosphodehydrogenase -69.30 and polynucleotide for coding it
10/30/2002	CN1376780A Polypeptide-threonine synthetase-9.35 and polynucleotide for coding it
10/30/2002	CN1376677A [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application
10/30/2002	CN1376519A Multi-enzyme complex capsule
10/30/2002	CN1376518A Stable lactase composition
10/30/2002	CN1376517A Medicine for preventing and treating renal fibrosis
10/30/2002	CN1376516A Injection-type compound bone repairing material containing more biological factors and using animal fibrin as carrier
10/30/2002	CN1376515A Medicine for preventing and treating nephrosis
10/30/2002	CN1376514A Injection-type bone morphogenetic protein using fibrin as carrier
10/30/2002	CN1093423C Novel brain endotheliai cell protein and methods for its use
10/30/2002	CN1093399C Small particle liposome aerosols for delivery of anti-cancer drugs
10/29/2002	US6472585 Cardiotrophin-1 defective mouse
10/29/2002	US6472537 Polyamides for binding in the minor groove of double stranded DNA
10/29/2002	US6472529 Viricides
10/29/2002	US6472521 Oligonucleotides for the inhibition of human eg5 expression
10/29/2002	US6472520 Rat PEG-3 promoter
10/29/2002	US6472518 Invasion associated genes from Neisseria meningitidis serogroup B
10/29/2002	US6472512 Keratinocyte derived interferon
10/29/2002	US6472511 Stimulation of an immune response with antibodies labeled with the α-galactosyl epitope
10/29/2002	US6472510 CD40 receptor ligands
10/29/2002	US6472509 Feline cytokine protein
10/29/2002	US6472508 Human tumor suppressor
10/29/2002	US6472507 Carrier based drug delivery system
10/29/2002	US6472505 Treatment of physiological conditions capable of being modulated by agonist or antagonist activity on parathyroid hormone receptors
10/29/2002	US6472504 Inhibitors of collagen assembly
10/29/2002	US6472411 Advanced glycation end-product intermediaries and post-amadori inhibition
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472403 αV integrin receptor antagonists
10/29/2002	US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002	US6472398 Spiropiperidine derivatives as melanocortin receptor agonists
10/29/2002	US6472390 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
10/29/2002	US6472377 Use of YNES, essential bacterial genes and polypeptides
10/29/2002	US6472376 Gene therapy
10/29/2002	US6472374 Endometrial function
10/29/2002	US6472373 Administering ribavirin and interferon-alpha
10/29/2002	US6472369 Anticancer compounds and methods
10/29/2002	US6472368 Compounds and methods for modulating adhesion molecule function
10/29/2002	US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002	US6472366 Hepatocyte growth factor for treatment of diabetes
10/29/2002	US6472225 Identifying a patient donor pair based on the measured in vitro immune responses of patient lymphocytes to donor allogeneic mononuclear cells (mnc) and determining the presence of antibodies
10/29/2002	US6472209 Using polyamide nucleic acid oligomers to engender a biological response
10/29/2002	US6472208 Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
10/29/2002	US6472197 GRB2 associating polypeptides and nucleic acids encoding therefor
10/29/2002	US6472195 Human kallikrein
10/29/2002	US6472183 Immunity against Actinobacillus pleuropneumoniae's RTX toxins APX
10/29/2002	US6472181 Hybrid matrix implants and explants
10/29/2002	US6472180 A polynucleotide which encodes a truncated fragment of the hcv ns3 (hepatitis c virus)ns3 protein helicase fragment, such truncated fragment retaining helicase activity and having about 50 amino acids of carboxy terminus deleted
10/29/2002	US6472179 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia
10/29/2002	US6472178 Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472170 BCL-Xy, a novel BCL-X isoform, and uses related thereto
10/29/2002	US6472162 Obtaining blood from a patient, sequestering plasma, adding ethanol in a concentration fo 8-20% to prepare a solution containing prothrombin, converting to thrombin, filtering and applying to a patient
10/29/2002	US6472142 Providing a cell with apoptin which interferes with bip/grp78-mediated apoptosis inhibiting activity; antitumor therapy
10/29/2002	US6472140 α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
10/29/2002	US6471993 Microstructure having voids located within said semi-solid network; tissue engineering scaffolds
10/29/2002	US6471978 Localized use of nitric oxide-adducts to prevent internal tissue damage
10/29/2002	US6471977 Parenteral release into the circulatory system of a cow of a bioactive bovine somatotropin, concentration of at least about 150 mg/ml; more than three days
10/29/2002	US6471970 Use of pharmaceutical compositions capable of being gelled in periodontology
10/29/2002	US6471968 Multifunctional nanodevice platform
10/29/2002	US6471967 Recombinant intracellular pathogen vaccines and methods for use
10/29/2002	US6471966 Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
10/29/2002	US6471964 Designated as structural protein-1 (sp-1), the isolated sp-1 protein, and use of the nucleic acid and/or protein for diagnostic or vaccine purposes
10/29/2002	US6471962 Monoclonal antibodies for infectious bursal disease, vaccines and assays for use therewith
10/29/2002	US6471961 Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
10/29/2002	US6471960 Methods for the prevention or treatment of alzheimer's disease
10/29/2002	US6471959 Human transferase
10/29/2002	US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002	US6471956 Ob polypeptides, modified forms and compositions thereto
10/29/2002	US6471500 Using a mammalian cell culture medium completely free of nonrecombinant mammalian proteins which are not derived from the host cells.
10/29/2002	EP1144613A4 Methods for making proteins containing free cysteine residues
10/29/2002	EP0960196A4 Novel receptor that causes cell death
10/29/2002	CA2221242C Viral agent associated with mystery swine disease
10/29/2002	CA2212747C Mhc-antigen complexes for detecting and purifying antigen-specific t cells
10/29/2002	CA2173102C Dna sequence coding for a bmp receptor

1 ... 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 ... 3163